Radiation-Emitting Products

MQSA Alternative Standard #8: Separate Assessment of Findings For Each Breast

FDA approved this alternative standard on July 3, 2003. It became effective on that date. It has no time limit. It allows the interpreting physician to provide a separate assessment of findings for each breast in the medical report, without the need to also provide an overall assessment of findings. Therefore, the interpreting physician can choose between providing separate assessments under this alternative or providing an overall assessment for the examination under the original standard.

The original standard is 21 CFR 900.12(c)(1)(iv), which states:

21 CFR 900.12(c)(1): Medical records and mammography reports

(iv) Overall assessment of findings, classified in one of the following categories:

The approved alternative is:

21 CFR 900.12(c)(1): Medical records and mammography reports

(iv) A separate assessment of findings for each breast, classified in one of the following categories:

The conditions of use of this alternative are that:

  • a single medical report covering the assessment of both breasts will be sent to the referring physician (or to the patient if there is no referring physician);
  • a single lay report will be sent to the patient, containing information based on the overall assessment for both breasts; and
  • even though separate assessments are made for each breast, the interpretation will count as only one examination towards meeting the MQSA experience requirements and will be billed as a single examination.

Back to Alternative Standards (MQSA)

Page Last Updated: 09/25/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.